BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang W, Wang CY, Dong JH, Chen X, Zhang M, Zhao G. Identification of effective siRNA against K-ras in human pancreatic cancer cell line MiaPaCa-2 by siRNA expression cassette. World J Gastroenterol 2005; 11(13): 2026-2031 [PMID: 15801000 DOI: 10.3748/wjg.v11.i13.2026]
URL: https://www.wjgnet.com/1007-9327/full/v11/i13/2026.htm
Number Citing Articles
1
J Wu, S Liu, J Yu, G Zhou, D Rao, C M Jay, P Kumar, R Sanchez, N Templeton, N Senzer, P Maples, J Nemunaitis, F C Brunicardi. Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platformCancer Gene Therapy 2014; 21(2): 48 doi: 10.1038/cgt.2013.84
2
A R R Forrest, M Kanamori-Katayama, Y Tomaru, T Lassmann, N Ninomiya, Y Takahashi, M J L de Hoon, A Kubosaki, A Kaiho, M Suzuki, J Yasuda, J Kawai, Y Hayashizaki, D A Hume, H Suzuki. Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulationLeukemia 2010; 24(2): 460 doi: 10.1038/leu.2009.246
3
Hong Dai, Razack Abdullah, Xiaoqiu Wu, Fangfei Li, Yuan Ma, Aiping Lu, Ge Zhang. Pancreatic Cancer: Nucleic Acid Drug Discovery and Targeted TherapyFrontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.855474
4
Harikumar Pallathadka, Majid Jabir, Khetam Habeeb Rasool, H. Malathi, Neha Sharma, Atreyi Pramanik, Safia Obaidur Rab, Sabrean Farhan Jawad, Enwa Felix Oghenemaro, Yasser Fakri Mustafa. siRNA-based therapy for overcoming drug resistance in human solid tumours; molecular and immunological approachesHuman Immunology 2025; 86(1): 111221 doi: 10.1016/j.humimm.2024.111221
5
S Y Wu, A Singhania, M Burgess, L N Putral, C Kirkpatrick, N M Davies, N A J McMillan. Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse modelsGene Therapy 2011; 18(1): 14 doi: 10.1038/gt.2010.113
6
Michael A. Morgan, Fredrick O. Onono, H. Peter Spielmann, Thangaiah Subramanian, Michaela Scherr, Letizia Venturini, Iris Dallmann, Arnold Ganser, Christoph W. M. Reuter. Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cellsJournal of Molecular Medicine 2012; 90(2): 149 doi: 10.1007/s00109-011-0814-7
7
Maung Nyan Win, Christina D. Smolke. RNA as a Versatile and Powerful Platform for Engineering Genetic Regulatory ToolsBiotechnology and Genetic Engineering Reviews 2007; 24(1): 311 doi: 10.1080/02648725.2007.10648106
8
Jin Xu, Chen Jin, Sijie Hao, Guopei Luo, Deliang Fu. Pancreatic cancer: gene therapy approaches and gene delivery systemsExpert Opinion on Biological Therapy 2010; 10(1): 73 doi: 10.1517/14712590903321454
9
Ezharul Hoque Chowdhury. Strategies for tumor-directed delivery of siRNAExpert Opinion on Drug Delivery 2011; 8(3): 389 doi: 10.1517/17425247.2011.554817
10
Shihe Liu, Nikiforos Ballian, Narasimhaswamy S. Belaguli, Sanjeet Patel, Min Li, Nancy Smyth Templeton, Marie-Claude Gingras, Richard Gibbs, William Fisher, F. Charles Brunicardi. PDX-1 Acts as a Potential Molecular Target for Treatment of Human Pancreatic CancerPancreas 2008; 37(2): 210 doi: 10.1097/MPA.0b013e31816a4a33
11
Francesco Mannavola, Tina Salerno, Anna Passarelli, Marco Tucci, Valeria Internò, Francesco Silvestris. Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00521
12
Sepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Masoud Delfi, Haroon Khan, Milad Ashrafizadeh, Gautam Sethi, Alan Prem Kumar. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapyCells 2021; 10(12): 3348 doi: 10.3390/cells10123348
13
S Vidic, B Markelc, G Sersa, A Coer, U Kamensek, G Tevz, S Kranjc, M Cemazar. MicroRNAs targeting mutant K-ras by electrotransfer inhibit human colorectal adenocarcinoma cell growth in vitro and in vivoCancer Gene Therapy 2010; 17(6): 409 doi: 10.1038/cgt.2009.87